Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis.
暂无分享,去创建一个
M. Rovaris | M. Filippi | A. Falini | G. Comi | G. Scotti | A. Gallo | B. Benedetti | P. Rossi | M. Comola
[1] David H. Miller,et al. Primary-progressive multiple sclerosis , 2007, The Lancet Neurology.
[2] J. Kamholz,et al. Neuronal cell injury precedes brain atrophy in multiple sclerosis , 2005, Neurology.
[3] Alan J. Thompson,et al. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis , 2004, NeuroImage.
[4] M. Esiri,et al. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. , 2004, Brain : a journal of neurology.
[5] Massimo Filippi,et al. Indirect evidence for early widespread gray matter involvement in relapsing–remitting multiple sclerosis , 2004, NeuroImage.
[6] M Rovaris,et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. , 2003, Brain : a journal of neurology.
[7] P Kapeller,et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[8] J. Babb,et al. Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations. , 2002, Radiology.
[9] Stephen M. Smith,et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.
[10] Marco Rovaris,et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. , 2002, Archives of neurology.
[11] M. Filippi,et al. Correlations between Structural CNS Damage and Functional MRI Changes in Primary Progressive MS , 2002, NeuroImage.
[12] Oded Gonen,et al. Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis. , 2002, AJNR. American journal of neuroradiology.
[13] G. Comi,et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. , 2001, Brain : a journal of neurology.
[14] B. Trapp,et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.
[15] Marco Rovaris,et al. Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis , 2000, Journal of Neurology.
[16] A J Thompson,et al. Diagnostic criteria for primary progressive multiple sclerosis: A position paper , 2000, Annals of neurology.
[17] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[18] A. Thompson,et al. One year follow up study of primary and transitional progressive multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.
[19] À. Rovira,et al. Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis , 2000, NMR in biomedicine.
[20] R I Grossman,et al. Total brain N-acetylaspartate , 2000, Neurology.
[21] Geoff J. M. Parker,et al. 1H Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis , 1999, Journal of Neurology.
[22] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.
[23] R I Grossman,et al. Total brain N‐acetylaspartate concentration in normal, age‐grouped females: Quantitation with non‐echo proton NMR spectroscopy , 1998, Magnetic resonance in medicine.
[24] D. MacManus,et al. H-1 magnetic resonance spectroscopy of normal-appearing white matter in primary progressive multiple sclerosis , 1998 .
[25] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[26] P M Matthews,et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques , 1992, Annals of neurology.
[27] J. Coyle,et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.
[28] A. Thompson,et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.
[29] P M Matthews,et al. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.
[30] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[31] J. Dehmeshki,et al. The normal appearing grey matter in primary progressive multiple sclerosis , 2003, Journal of Neurology.
[32] F. Barkhof,et al. Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.